Staber & Kollegen GmbH MVZ für Humangenetik Regensburg
Official name: Dr. Staber & Kollegen GmbH MVZ für Humangenetik Regensburg
168 capabilities
Accredited since September 2026
Verified Oct 2026
One of 3,209 in Germany
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Bischof-von-Henle-Straße 2a
Regensburg 93051 , Germany
Regensburg 93051 , Germany
Accreditation
Active
DAkkS
D-ML-13252-03-01
www.genetik-regensburg.de/
Prefer to enquire through us? Send an enquiry
Accreditation Details
Accreditation Body
DAkkS
Number
D-ML-13252-03-01
Status
ActiveSince
22 September 2026
Accreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official DAkkS records.
Download Scope PDFAdditional scope documents
Test Capabilities (168)
| Standard Reference | Description | Category |
|---|---|---|
| Arrhythmogene rechtsventrikuläre | Arrhythmogene rechtsventrikuläre | Biocompatibility (ISO 10993) |
| (NM_000038), BMPR1A | (NM_000038), BMPR1A | Biological / Microbiological |
| (NM_004329), CHEK2 | (NM_004329), CHEK2 | Biological / Microbiological |
| HBA2 | HbA2 | Chromatography (GC, HPLC) |
| APC | APC | Clinical Chemistry |
| C3 | MYBPC3 | Elemental Analysis |
| CAV3 | CAV3 | Elemental Analysis |
| Catecholaminerge polymorphe | Catecholaminerge polymorphe | Elemental Analysis |
| DSC2 | DSC2 | Elemental Analysis |
| DSG2 | DSG2 | Elemental Analysis |
| KCNE1 | KCNE1 | Elemental Analysis |
| KCNE2 | KCNE2 | Elemental Analysis |
| KCNH2 | KCNH2 | Elemental Analysis |
| KCNQ1 | KCNQ1 | Elemental Analysis |
| MYH7 | MYH7 | Elemental Analysis |
| PKP2 | PKP2 | Elemental Analysis |
| RYR2 | RYR2 | Elemental Analysis |
| SCN5A | SCN5A | Elemental Analysis |
| TGFBR2 | TGFBR2 | Elemental Analysis |
| TNNT2 | TNNT2 | Elemental Analysis |
| (HPF, hereditäre Fiebersyndrome; MEFV, ADA2, ELANE, IL1RN, IL36RN, LPIN2, MVK, NLRC4, NLRP12, NLRP3, NOD2, PSMB8, PSTPIP1, TNFRSF1A ); SNV, CNV | (HPF, hereditäre Fiebersyndrome; MEFV, ADA2, ELANE, IL1RN, IL36RN, LPIN2, MVK, NLRC4, NLRP12, NLRP3, NOD2, PSMB8, PSTPIP1, TNFRSF1A ); SNV, CNV | Molecular Diagnostics / PCR |
| (NM_000179), PALB2 | (NM_000179), PALB2 | Molecular Diagnostics / PCR |
| (NM_017763), SMAD4 | (NM_017763), SMAD4 | Molecular Diagnostics / PCR |
| (OMIM 601728), RAD51C | (OMIM 601728), RAD51C | Molecular Diagnostics / PCR |
| ATM | ATM | Molecular Diagnostics / PCR |
| ATP7B | Panel; HFE, HJV, HAMP, FTL, TMPRSS6, ATP7B | Molecular Diagnostics / PCR |
| Adenomatöse Polyposis | Familiäre Adenomatöse Polyposis | Molecular Diagnostics / PCR |
| Aortenaneurysma (ACTA2, COL3A1, FBN1, MYH11, MYLK, SMAD3, TGFB2, TGFBR1, TGFBR2 ); SNV, CNV | Aortenaneurysma (ACTA2, COL3A1, FBN1, MYH11, MYLK, SMAD3, TGFB2, TGFBR1, TGFBR2 ); SNV, CNV | Molecular Diagnostics / PCR |
| Azoospermie (Azoospermiefaktor (AZF )-Deletion) | Azoospermie (Azoospermiefaktor (AZF )-Deletion) | Molecular Diagnostics / PCR |
| BAG3 | BAG3 | Molecular Diagnostics / PCR |
| BRAF | BRAF | Molecular Diagnostics / PCR |
| BRCA-Diagnostik vor PARP- Inhibitoren-Therapie (BRCA1 , BRCA2 ); SNV, CNV | BRCA-Diagnostik vor PARP- Inhibitoren-Therapie (BRCA1 , BRCA2 ); SNV, CNV | Molecular Diagnostics / PCR |
| BRCA1 | BRCA1 | Molecular Diagnostics / PCR |
| BRCA1/BRCA2 | BRCA1/BRCA2: ID001 | Molecular Diagnostics / PCR |
| BRIP1 | BRIP1 | Molecular Diagnostics / PCR |
| Behçet, Morbus (HLA-B51) | Behçet, Morbus (HLA-B51) | Molecular Diagnostics / PCR |
| Brugada-Syndrom (SCN5A, CACNA1C, CACNB2, GPD1L, HCN4, KCND3, KCNE3, SCN1B, SCN3B, TRPM4 ); SNV, CNV | Brugada-Syndrom (SCN5A, CACNA1C, CACNB2, GPD1L, HCN4, KCND3, KCNE3, SCN1B, SCN3B, TRPM4 ); SNV, CNV | Molecular Diagnostics / PCR |
| Brust- und Ovarialkarzinom, hereditär (HBOC; BRCA1 , BRCA2 , CHEK2 , PALB2 , RAD51C, TP53 ); SNV, CNV | Brust- und Ovarialkarzinom, hereditär (HBOC; BRCA1 , BRCA2 , CHEK2 , PALB2 , RAD51C, TP53 ); SNV, CNV | Molecular Diagnostics / PCR |
| Brust- und Ovarialkarzinom, hereditär, erweiterte Diagnostik (ATM , BARD1, BRIP1 , CDH1, PTEN, STK11, RAD51D, SMARCA4 ); SNV, CNV | Brust- und Ovarialkarzinom, hereditär, erweiterte Diagnostik (ATM , BARD1, BRIP1 , CDH1, PTEN, STK11, RAD51D, SMARCA4 ); SNV, CNV | Molecular Diagnostics / PCR |
| CDH1 | CDH1 | Molecular Diagnostics / PCR |
| CDK4 | CDK4 | Molecular Diagnostics / PCR |
| CDKN2A | CDKN2A | Molecular Diagnostics / PCR |
| CEL | CEL | Molecular Diagnostics / PCR |
| CFTR | CFTR | Molecular Diagnostics / PCR |
| COL1A1 | COL1A1 | Molecular Diagnostics / PCR |
| COL1A1, COL1A2, COL3A1, COL5A1, COL5A2, PLOD1 | COL1A1, COL1A2, COL3A1, COL5A1, COL5A2, PLOD1 | Molecular Diagnostics / PCR |
| COL3A1 | TGFBR1, TGFBR2, COL3A1 | Molecular Diagnostics / PCR |
| CTRC | CTRC | Molecular Diagnostics / PCR |
| Cystische Fibrose (Mukoviszidose und CBAVD; CFTR ); SNV, CNV | Cystische Fibrose (Mukoviszidose und CBAVD; CFTR ); SNV, CNV | Molecular Diagnostics / PCR |
| DSP | DSP | Molecular Diagnostics / PCR |
| DiGeorge-Syndrom (Mikrodeletion 22q11.2, CATCH22) | DiGeorge-Syndrom (Mikrodeletion 22q11.2, CATCH22) | Molecular Diagnostics / PCR |
| Diagnostik (BRCA1, BRCA2, CDKN2A, PALB2, STK11, TP53, APC, ATM, CDC73, CHEK2, MLH1, MSH2, MSH6, PMS2, PTEN ); SNV, CNV | Diagnostik (BRCA1, BRCA2, CDKN2A, PALB2, STK11, TP53, APC, ATM, CDC73, CHEK2, MLH1, MSH2, MSH6, PMS2, PTEN ); SNV, CNV | Molecular Diagnostics / PCR |
| Diagnostik (BRCA2, ATM, BRCA1, CDH1, CHEK2, FANCA, HOXB13, PALB2 ); SNV, CNV | Diagnostik (BRCA2, ATM, BRCA1, CDH1, CHEK2, FANCA, HOXB13, PALB2 ); SNV, CNV | Molecular Diagnostics / PCR |
| Diagnostik (CDH1, APC, ATM, BMPR1A, BRCA1, BRCA2, CHEK2, MLH1, MSH2, MSH6, MUTYH, PMS2, PTEN, SMAD4, STK11, TP53 ); SNV, CNV | Diagnostik (CDH1, APC, ATM, BMPR1A, BRCA1, BRCA2, CHEK2, MLH1, MSH2, MSH6, MUTYH, PMS2, PTEN, SMAD4, STK11, TP53 ); SNV, CNV | Molecular Diagnostics / PCR |
| Diagnostik (FH, FLCN, MET, BAP1, CHEK2, DICER1, DIS3L2, MLH1, MSH2, MSH6, PMS2, PTEN, SDHB, SDHD, SMARCB1, TP53, TSC1, TSC2, VHL, WT1 ); SNV, CNV | Diagnostik (FH, FLCN, MET, BAP1, CHEK2, DICER1, DIS3L2, MLH1, MSH2, MSH6, PMS2, PTEN, SDHB, SDHD, SMARCB1, TP53, TSC1, TSC2, VHL, WT1 ); SNV, CNV | Molecular Diagnostics / PCR |
| EPCAM | EPCAM | Molecular Diagnostics / PCR |
| Ehlers-Danlos-Syndrom (COL1A1, COL1A2, COL3A1, COL5A1, COL5A2, TNXB, ADAMTS2, AEBP1, FKBP14, PLOD1, SLC39A13 ); SNV, CNV | Ehlers-Danlos-Syndrom (COL1A1, COL1A2, COL3A1, COL5A1, COL5A2, TNXB, ADAMTS2, AEBP1, FKBP14, PLOD1, SLC39A13 ); SNV, CNV | Molecular Diagnostics / PCR |
| Ehlers-Danlos-Syndrom (seltene Formen inkl. Brittle-Cornea- Syndrom) (B3GALT6, B4GALT7, C1R, C1S, CHST14, COL12A1, DSE, PRDM5, ZNF469 ); SNV, CNV | Ehlers-Danlos-Syndrom (seltene Formen inkl. Brittle-Cornea- Syndrom) (B3GALT6, B4GALT7, C1R, C1S, CHST14, COL12A1, DSE, PRDM5, ZNF469 ); SNV, CNV | Molecular Diagnostics / PCR |
| FBN1 | FBN1 | Molecular Diagnostics / PCR |
| FLCN | FLCN | Molecular Diagnostics / PCR |
| Familiäre Hypercholesterinämie (LDLR, APOB, LDLRAP1, PCSK9 ); SNV, CNV | Familiäre Hypercholesterinämie (LDLR, APOB, LDLRAP1, PCSK9 ); SNV, CNV | Molecular Diagnostics / PCR |
| Familiäre juvenile Polyposis (FJP; BMPR1A , SMAD4 ); SNV, CNV | Familiäre juvenile Polyposis (FJP; BMPR1A , SMAD4 ); SNV, CNV | Molecular Diagnostics / PCR |
| Fragiles-X-Syndrom (FMR1 ) | Fragiles-X-Syndrom (FMR1 ) | Molecular Diagnostics / PCR |
| Fragiles-X-assoziiertes Tremor- Ataxie-Syndrom (FXTAS, FMR1 ) | Fragiles-X-assoziiertes Tremor- Ataxie-Syndrom (FXTAS, FMR1 ) | Molecular Diagnostics / PCR |
| GCK | GCK | Molecular Diagnostics / PCR |
| GLA | GLA | Molecular Diagnostics / PCR |
| GPC3 | GPC3 | Molecular Diagnostics / PCR |
| GPC4 | GPC4 | Molecular Diagnostics / PCR |
| GREM1 | GREM1 | Molecular Diagnostics / PCR |
| Gonadendysgenesie (SRY ) | Gonadendysgenesie (SRY ) | Molecular Diagnostics / PCR |
| HBA1 | HBA1 | Molecular Diagnostics / PCR |
| HBB | HBB | Molecular Diagnostics / PCR |
| HNF1A | HNF1A | Molecular Diagnostics / PCR |
| HNF1B | MODY-Panel; GCK, HNF1A, PDX1, HNF1B | Molecular Diagnostics / PCR |
| HNF4A | HNF4A | Molecular Diagnostics / PCR |
| Hereditäres Non-Polypöses Colon- Karzinom (HNPCC/ Lynch-Syndrom; MLH1 , PMS2 , MSH6 , MSH2 ); SNV, CNV | Hereditäres Non-Polypöses Colon- Karzinom (HNPCC/ Lynch-Syndrom; MLH1 , PMS2 , MSH6 , MSH2 ); SNV, CNV | Molecular Diagnostics / PCR |
| Hereditäres Periodisches Fieber | Hereditäres Periodisches Fieber | Molecular Diagnostics / PCR |
| Hypertrophe Kardiomyopathie (MYBPC3, MYH7, TNNI3, TNNT2, ACTC1, ACTN2, ALPK3, CSRP3, JPH2, MYL2, MYL3, PLN, TNNC1, TPM1 ); SNV, CNV | Hypertrophe Kardiomyopathie (MYBPC3, MYH7, TNNI3, TNNT2, ACTC1, ACTN2, ALPK3, CSRP3, JPH2, MYL2, MYL3, PLN, TNNC1, TPM1 ); SNV, CNV | Molecular Diagnostics / PCR |
| Hämoglobin-Genotypisierung (Thalassämie-alpha (HBA1 , HBA2 ) und Thalassämie-beta (HBB )) | Hämoglobin-Genotypisierung (Thalassämie-alpha (HBA1 , HBA2 ) und Thalassämie-beta (HBB )) | Molecular Diagnostics / PCR |
| INS | INS | Molecular Diagnostics / PCR |
| JUP | JUP | Molecular Diagnostics / PCR |
| JUP, TGFB3 | JUP, TGFB3 | Molecular Diagnostics / PCR |
| KCNJ2 | KCNJ2 | Molecular Diagnostics / PCR |
| KLF11 | KLF11 | Molecular Diagnostics / PCR |
| KRAS | KRAS | Molecular Diagnostics / PCR |
| Kardiodysplasie (ARVD; DSC2, DSG2, DSP, FLNC, JUP, PKP2, PLN, CDH2, CTNNA3, DES, TGFB3, TMEM43 ); SNV, CNV | Kardiodysplasie (ARVD; DSC2, DSG2, DSP, FLNC, JUP, PKP2, PLN, CDH2, CTNNA3, DES, TGFB3, TMEM43 ); SNV, CNV | Molecular Diagnostics / PCR |
| Kolonkarzinom (TP53 , CHEK2 , MUTYH , POLE , POLD1 , PTEN , STK11 ); SNV, CNV | Kolonkarzinom (TP53 , CHEK2 , MUTYH , POLE , POLD1 , PTEN , STK11 ); SNV, CNV | Molecular Diagnostics / PCR |
| Kolonkarzinom mit Polyposis (APC , BMPR1A , MUTYH , SMAD4 , GREM1 , MSH3 , NTHL1 , PTEN , POLD1 , POLE , STK11 ); SNV, CNV | Kolonkarzinom mit Polyposis (APC , BMPR1A , MUTYH , SMAD4 , GREM1 , MSH3 , NTHL1 , PTEN , POLD1 , POLE , STK11 ); SNV, CNV | Molecular Diagnostics / PCR |
| LDLR | LDLR | Molecular Diagnostics / PCR |
| LMNA | LMNA | Molecular Diagnostics / PCR |
| Li-Fraumeni-Syndrom / TPDS (TP53 , BAP1 , CHEK2 , POT1 ); SNV, CNV | Li-Fraumeni-Syndrom / TPDS (TP53 , BAP1 , CHEK2 , POT1 ); SNV, CNV | Molecular Diagnostics / PCR |
| Loeys-Dietz-Syndrom (TGFBR1, TGFBR2, SMAD2, SMAD3, TGFB2, TGFB3 ); SNV, CNV | Loeys-Dietz-Syndrom (TGFBR1, TGFBR2, SMAD2, SMAD3, TGFB2, TGFB3 ); SNV, CNV | Molecular Diagnostics / PCR |
| Long-QT-Syndrom (KCNH2, KCNQ1, SCN5A, AKAP9, ANK2, CACNA1C, CALM1, CALM2, CALM3, CAV3, KCNE1, KCNE2, KCNJ2, KCNJ5, SCN4B, SNTA1, TRDN ); SNV, CNV | Long-QT-Syndrom (KCNH2, KCNQ1, SCN5A, AKAP9, ANK2, CACNA1C, CALM1, CALM2, CALM3, CAV3, KCNE1, KCNE2, KCNJ2, KCNJ5, SCN4B, SNTA1, TRDN ); SNV, CNV | Molecular Diagnostics / PCR |
| MEN1 | MEN1 | Molecular Diagnostics / PCR |
| MET | MET | Molecular Diagnostics / PCR |
| MLH1 | MLH1 | Molecular Diagnostics / PCR |
| MLPA für STK11 | MLPA für STK11 | Molecular Diagnostics / PCR |
| MSH2 | MSH2 | Molecular Diagnostics / PCR |
| MSH6 | MSH6 | Molecular Diagnostics / PCR |
| MUTYH | MUTYH | Molecular Diagnostics / PCR |
| Magenkarzinom (CDH1 , BMPR1A , CHEK2 , MLH1 , MSH2 , MSH6 , PMS2 , PTEN, SMAD4 , STK11 , TP53 ); SNV, CNV | Magenkarzinom (CDH1 , BMPR1A , CHEK2 , MLH1 , MSH2 , MSH6 , PMS2 , PTEN, SMAD4 , STK11 , TP53 ); SNV, CNV | Molecular Diagnostics / PCR |
| Magenkarzinom, erweiterte | Magenkarzinom, erweiterte | Molecular Diagnostics / PCR |
| Marfan-Syndrom (FBN1, TGFBR1, TGFBR2 ); SNV, CNV | Marfan-Syndrom (FBN1, TGFBR1, TGFBR2 ); SNV, CNV | Molecular Diagnostics / PCR |
| Maturity Onset Diabetes of the | Maturity-onset diabetes of the | Molecular Diagnostics / PCR |
| Mittelmeerfieber, hereditär (MEFV ); SNV, CNV | Mittelmeerfieber, hereditär (MEFV ); SNV, CNV | Molecular Diagnostics / PCR |
| Morbus Wilson (ATP7B ); SNV, CNV | Morbus Wilson (ATP7B ); SNV, CNV | Molecular Diagnostics / PCR |
| NEUROD1 | NEUROD1 | Molecular Diagnostics / PCR |
| NF1 | NF1 | Molecular Diagnostics / PCR |
| NF1, DD Legius-Syndrom (NF1, SPRED1 ); SNV, CNV | NF1, DD Legius-Syndrom (NF1, SPRED1 ); SNV, CNV | Molecular Diagnostics / PCR |
| NSD1 | NSD1 | Molecular Diagnostics / PCR |
| Narkolepsie (Haplotyp DQB1*06:02, HLA-DR15/DQ6) | Narkolepsie (Haplotyp DQB1*06:02, HLA-DR15/DQ6) | Molecular Diagnostics / PCR |
| Neurofibromatose Typ 1 (NF1 ); SNV, CNV | Neurofibromatose Typ 1 (NF1 ); SNV, CNV | Molecular Diagnostics / PCR |
| Nierenkarzinom (FH , FLCN , MET , CHEK2 , PTEN , SMARCB1 , TP53 , TSC1 , TSC2 , VHL ); SNV, CNV | Nierenkarzinom (FH , FLCN , MET , CHEK2 , PTEN , SMARCB1 , TP53 , TSC1 , TSC2 , VHL ); SNV, CNV | Molecular Diagnostics / PCR |
| Nierenkarzinom, erweiterte | Nierenkarzinom, erweiterte | Molecular Diagnostics / PCR |
| Non-Compaction Kardiomyopathie (ACTC1, MYH7, PRDM16, TAZ (TAFAZZIN), TPM1, ACTN2, DTNA, MIB1, LDB3, MYBPC3, TNNT2 ); SNV, CNV | Non-Compaction Kardiomyopathie (ACTC1, MYH7, PRDM16, TAZ (TAFAZZIN), TPM1, ACTN2, DTNA, MIB1, LDB3, MYBPC3, TNNT2 ); SNV, CNV | Molecular Diagnostics / PCR |
| Noonan-Syndrom (Stufe I: PTPN11 , Stufe II: BRAF, KRAS, RAF1, RIT1, SOS1 ); SNV, CNV | Noonan-Syndrom (Stufe I: PTPN11 Stufe II: BRAF, KRAS, RAF1, RIT1, SOS1 ); SNV, CNV | Molecular Diagnostics / PCR |
| Ovarialkarzinom (BRCA1, BRCA2, BRIP1, MLH1, MSH2, MSH6, PALB2, RAD51C, RAD51D, STK11 ); SNV, CNV | Ovarialkarzinom (BRCA1, BRCA2, BRIP1, MLH1, MSH2, MSH6, PALB2, RAD51C, RAD51D, STK11 ); SNV, CNV | Molecular Diagnostics / PCR |
| Ovarialkarzinom - ohne BRCA1 / BRCA2 (BRIP1, MLH1, MSH2, MSH6, PALB2, RAD51C, RAD51D, STK11 ); SNV, CNV | Ovarialkarzinom - ohne BRCA1 / BRCA2 (BRIP1, MLH1, MSH2, MSH6, PALB2, RAD51C, RAD51D, STK11 ); SNV, CNV | Molecular Diagnostics / PCR |
| PAX4 | PAX4 | Molecular Diagnostics / PCR |
| PDX1 | PDX1 | Molecular Diagnostics / PCR |
| PMS2 | PMS2 | Molecular Diagnostics / PCR |
| POLD1 | POLD1 | Molecular Diagnostics / PCR |
| POLE | POLE | Molecular Diagnostics / PCR |
| PROC | PROC | Molecular Diagnostics / PCR |
| PROS1 | PROS1 | Molecular Diagnostics / PCR |
| PRSS1 | PRSS1 | Molecular Diagnostics / PCR |
| PTCH1 | PTCH1 | Molecular Diagnostics / PCR |
| PTEN | PTEN | Molecular Diagnostics / PCR |
| Pankreaskarzinom (BRCA1 , BRCA2 , CDKN2A , PALB2 , STK11 , TP53 ); SNV, CNV | Pankreaskarzinom (BRCA1 , BRCA2 , CDKN2A , PALB2 , STK11 , TP53 ); SNV, CNV | Molecular Diagnostics / PCR |
| Pankreaskarzinom, PARP- Inhibitoren-Therapie (BRCA1 , BRCA2 ); SNV, CNV | Pankreaskarzinom, PARP- Inhibitoren-Therapie (BRCA1 , BRCA2 ); SNV, CNV | Molecular Diagnostics / PCR |
| Pankreaskarzinom, erweiterte | Pankreaskarzinom, erweiterte | Molecular Diagnostics / PCR |
| Pankreatitis, hereditär (PRSS1, SPINK1/PSTI, CFTR, CPA1, CTRC ); SNV, CNV | Pankreatitis, hereditär (PRSS1, SPINK1/PSTI, CFTR, CPA1, CTRC ); SNV, CNV | Molecular Diagnostics / PCR |
| Papilläres Schilddrüsenkarzinom, familiäres nichtmedulläres | Papilläres Schilddrüsenkarzinom, familiäres nichtmedulläres | Molecular Diagnostics / PCR |
| Paragangliom-Phäochromozytom- Syndrom (RET , SDHAF2 , SDHA , SDHB , SDHC , SDHD , VHL , MAX , MEN1 , NF1 , TMEM127 ); SNV, CNV | Paragangliom-Phäochromozytom- Syndrom (RET , SDHAF2 , SDHA , SDHB , SDHC , SDHD , VHL , MAX , MEN1 , NF1 , TMEM127 ); SNV, CNV | Molecular Diagnostics / PCR |
| Prostatakarzinom (BRCA2 , ATM , BRCA1 ); SNV, CNV | Prostatakarzinom (BRCA2 , ATM , BRCA1 ); SNV, CNV | Molecular Diagnostics / PCR |
| Prostatakarzinom, PARP-Inhibitoren- Therapie (BRCA2 , BRCA1 ); SNV, CNV | Prostatakarzinom, PARP-Inhibitoren- Therapie (BRCA2 , BRCA1 ); SNV, CNV | Molecular Diagnostics / PCR |
| Prostatakarzinom, erweiterte | Prostatakarzinom, erweiterte | Molecular Diagnostics / PCR |
| Protein C-Defizienz (PROC ); SNV, CNV | Protein C-Defizienz (PROC ); SNV, CNV | Molecular Diagnostics / PCR |
| Protein S-Defizienz (PROS1 ); SNV, CNV | Protein S-Defizienz (PROS1 ); SNV, CNV | Molecular Diagnostics / PCR |
| Prämature Ovarialinsuffizienz (POF/FXPOI, FMR1 ) | Prämature Ovarialinsuffizienz (POF/FXPOI, FMR1 ) | Molecular Diagnostics / PCR |
| RAD51D | RAD51D | Molecular Diagnostics / PCR |
| Restriktive Kardiomyopathie (TNNI3, FLNC, KIF20A, MYPN, TNNT2 ); SNV, CNV | Restriktive Kardiomyopathie (TNNI3, FLNC, KIF20A, MYPN, TNNT2 ); SNV, CNV | Molecular Diagnostics / PCR |
| SHOX | SHOX | Molecular Diagnostics / PCR |
| SHOX-Defizienz (SHOX ); SNV, CNV | SHOX-Defizienz (SHOX ); SNV, CNV | Molecular Diagnostics / PCR |
| SPINK1 | SPINK1 | Molecular Diagnostics / PCR |
| Schilddrüsenkarzinom (APC, BAP1, CHEK2, DICER1, PRKAR1A, PTEN, TP53 ); SNV, CNV | Schilddrüsenkarzinom (APC, BAP1, CHEK2, DICER1, PRKAR1A, PTEN, TP53 ); SNV, CNV | Molecular Diagnostics / PCR |
| Short-QT-Syndrom (KCNH2, KCNJ2, KCNQ1, CACNA1C, CACNB2 ); SNV, CNV | Short-QT-Syndrom (KCNH2, KCNJ2, KCNQ1, CACNA1C, CACNB2 ); SNV, CNV | Molecular Diagnostics / PCR |
| Sichelzellanämie (HbS-Mutation in HBB ) | Sichelzellanämie (HbS-Mutation in HBB ) | Molecular Diagnostics / PCR |
| Sotos-Syndrom (NSD1, PTEN, PTCH1, GPC3 ); SNV, CNV | Sotos-Syndrom (NSD1, PTEN, PTCH1, GPC3 ); SNV, CNV | Molecular Diagnostics / PCR |
| TP53 | TP53 | Molecular Diagnostics / PCR |
| TSC1 | TSC1 | Molecular Diagnostics / PCR |
| TSC2 | TSC2 | Molecular Diagnostics / PCR |
| Thalassämie-alpha (HBA1 , HBA2 ) | Thalassämie-alpha (HBA1 , HBA2 ) | Molecular Diagnostics / PCR |
| Thalassämie-beta (HBB ) | Thalassämie-beta (HBB ) | Molecular Diagnostics / PCR |
| Tuberöse Sklerose (TSC1 , TSC2 ); SNV, CNV | Tuberöse Sklerose (TSC1 , TSC2 ); SNV, CNV | Molecular Diagnostics / PCR |
| Tumorprädispositionssyndrome (individuell); SNV, CNV | Tumorprädispositionssyndrome (individuell); SNV, CNV | Molecular Diagnostics / PCR |
| Young (MODY; HNF4A, GCK, HNF1A, PDX1, HNF1B, NEUROD1, KLF11, CEL, PAX4, INS, BLK, ABCC8, KCNJ11, APPL1 ); SNV, CNV | Young (MODY; HNF4A, GCK, HNF1A, PDX1, HNF1B, NEUROD1, KLF11, CEL, PAX4, INS, BLK, ABCC8, KCNJ11, APPL1 ); SNV, CNV | Molecular Diagnostics / PCR |
| [hereditary Cancer-Panel] | [hereditary Cancer-Panel] | Molecular Diagnostics / PCR |
| coli (FAP/MAP; APC , MUTYH ); SNV, CNV | coli (FAP/MAP; APC , MUTYH ); SNV, CNV | Molecular Diagnostics / PCR |
| malignes Melanom (CDKN2A, CDK4, ACD, BAP1, MITF, POT1, TERF2IP, TERT ); SNV, CNV | malignes Melanom (CDKN2A, CDK4, ACD, BAP1, MITF, POT1, TERF2IP, TERT ); SNV, CNV | Molecular Diagnostics / PCR |
| ventrikuläre Tachykardie (RYR2, CALM1, CALM2, CALM3, CASQ2, KCNJ2, TECRL, TRDN ); SNV, CNV | ventrikuläre Tachykardie (RYR2, CALM1, CALM2, CALM3, CASQ2, KCNJ2, TECRL, TRDN ); SNV, CNV | Molecular Diagnostics / PCR |
| CNV | CNV | Other |
| FH | FH | Other |
| SNV, CNV | SNV, CNV | Other |
| [Custom Panel] | [Custom Panel] | Other |
| [Targeted DNA Custom Panel] | [Targeted DNA Custom Panel] | Other |
| COL5A1 | COL5A1 | Spectroscopy (XRF, ICP, AAS) |
| ABCC8 | ABCC8 | Sterility Testing |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.